Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K H Eckels

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
The Journal of Allergy and Clinical Immunology|December 1, 1984
Human hypersensitivity to a sham vaccine prepared from mosquito-cell culture fluidsR M Scott, A L Shelton, K H Eckels, et al.
Vaccine|March 30, 2011
A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illnessV J Gunther, R Putnak, K H Eckels, et al.
Journal of Virological Methods|June 1, 1990
Preparation of noninfectious hepatitis A virus hemagglutinin for detecting hemagglutination inhibition antibodiesD R Dubois, L N Binn, P L Summers, et al.
Journal of Virology|October 1, 1993
Dengue virus-specific human CD4+ T-lymphocyte responses in a recipient of an experimental live-attenuated dengue virus type 1 vaccine: bulk culture proliferation, clonal analysis, and precursor frequency determinationS Green, I Kurane, R Edelman, et al.
The Journal of Infectious Diseases|December 1, 1983
Dengue 2 vaccine: dose response in volunteers in relation to yellow fever immune statusR M Scott, K H Eckels, W H Bancroft, et al.
The American Journal of Tropical Medicine and Hygiene|August 1, 1990
Preparation of an attenuated dengue 4 (341750 Carib) virus vaccine. I. Pre-clinical studiesN J Marchette, D R Dubois, L K Larsen, et al.
Infection and Immunity|January 1, 1980
Dengue-2 vaccine: viremia and immune responses in rhesus monkeysR M Scott, A Nisalak, K H Eckels, et al.
The American Journal of Tropical Medicine and Hygiene|July 1, 1984
Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. V. Human response to immunization with a candidate vaccine prepared in fetal rhesus lung cellsK H Eckels, R M Scott, W H Bancroft, et al.
The Journal of Infectious Diseases|December 1, 1994
A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humansR Edelman, C O Tacket, S S Wasserman, et al.
The Journal of Infectious Diseases|December 1, 1996
Development of a purified, inactivated, dengue-2 virus vaccine prototype in Vero cells: immunogenicity and protection in mice and rhesus monkeysR Putnak, D A Barvir, J M Burrous, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
The Journal of Allergy and Clinical Immunology|December 1, 1984
Human hypersensitivity to a sham vaccine prepared from mosquito-cell culture fluidsR M Scott, A L Shelton, K H Eckels, et al.
Vaccine|March 30, 2011
A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illnessV J Gunther, R Putnak, K H Eckels, et al.
Journal of Virological Methods|June 1, 1990
Preparation of noninfectious hepatitis A virus hemagglutinin for detecting hemagglutination inhibition antibodiesD R Dubois, L N Binn, P L Summers, et al.
Journal of Virology|October 1, 1993
Dengue virus-specific human CD4+ T-lymphocyte responses in a recipient of an experimental live-attenuated dengue virus type 1 vaccine: bulk culture proliferation, clonal analysis, and precursor frequency determinationS Green, I Kurane, R Edelman, et al.
The Journal of Infectious Diseases|December 1, 1983
Dengue 2 vaccine: dose response in volunteers in relation to yellow fever immune statusR M Scott, K H Eckels, W H Bancroft, et al.
The American Journal of Tropical Medicine and Hygiene|August 1, 1990
Preparation of an attenuated dengue 4 (341750 Carib) virus vaccine. I. Pre-clinical studiesN J Marchette, D R Dubois, L K Larsen, et al.
Infection and Immunity|January 1, 1980
Dengue-2 vaccine: viremia and immune responses in rhesus monkeysR M Scott, A Nisalak, K H Eckels, et al.
The American Journal of Tropical Medicine and Hygiene|July 1, 1984
Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. V. Human response to immunization with a candidate vaccine prepared in fetal rhesus lung cellsK H Eckels, R M Scott, W H Bancroft, et al.
The Journal of Infectious Diseases|December 1, 1994
A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humansR Edelman, C O Tacket, S S Wasserman, et al.
The Journal of Infectious Diseases|December 1, 1996
Development of a purified, inactivated, dengue-2 virus vaccine prototype in Vero cells: immunogenicity and protection in mice and rhesus monkeysR Putnak, D A Barvir, J M Burrous, et al.
Pageof 6